Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Endothelin antagonists from Banyu

Oct. 11, 1996

Warner-Lambert claims endothelin antagonists

Oct. 11, 1996

Further patent coverage for vascular disease therapy

Oct. 4, 1996

New bi-ventricular pacemaker enters clinical trials

Oct. 4, 1996

HemoCleanse evaluates sorbent-based system in sepsis

Oct. 4, 1996

T Cell Sciences receives grant to develop CETP vaccine

Oct. 4, 1996

Alexion authorized to begin second clinical trial with C5 inhibitor

Oct. 4, 1996

TMR as adjunct to bypass surgery

Oct. 4, 1996

Prodesfarma presents cardiovascular candidate

Oct. 4, 1996

Cardiovascular R&D at Takeda

Sep. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for February 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...